Institut Bordet - Retour à la page d'accueil
en
I want to donate to research

Clinical Trials Conduct Unit (CTCU)

The role of the Clinical Trials Conduct Unit (CTCU) is to conduct clinical studies in a professional manner, in compliance with European Directives, regulations and Good Clinical Practice – GCP). These clinical studies are carried out in collaboration with pharmaceutical firms and/or academic partners. The Institut Bordet also implements its own clinical studies.  

Clinical studies are very closely monitored and must meet the quality criteria essential for ensuring that patients who participate in the studies are protected, while also maintaining a very high level of medical care. Patient well-being is always at the centre of our concerns. The link between the CTCU and the various medical departments is very close. A specific care unit is devoted solely to welcoming patients included in clinical trials: the Novel Treatment Unit.

The clinical studies conducted at the Institut Bordet are coordinated by CTCU research physicians and teams. These doctors are responsible for monitoring patients and collecting data.

Research projects

Project 1 (PROJECT FINALIZED BUT NOT YET USED IN PRACTICE ...)

Development of a multimedia support tool for consent to participate in a clinical study

Project 2 (ongoing)

Development of a quality improvement and care safety programme in compliance with good clinical practice

Project 3 (ongoing)

Développement d’un outil informatique assurant l’amélioration du recueil des données cliniques relatives à la recherche (effets secondaires, médicaments concomitants, histoire médicale du patient)

Our team

Under the responsibility of the research physician, the clinical research nurses and clinical study coordinators organise and coordinate the different aspects of the clinical studies. They are the point of contact for patients participating in clinical trials and also for all our research partners. They provide personalised support for the patient and are the primary contact throughout treatment.

Explanation of roles:

  • The principal researcher is a doctor who manages the execution of the clinical trial on our site. He undertakes to conduct the research in accordance with good clinical practice and in line with the protocol. He appoints his collaborators and determines their role in the study.
  • The co-researchers are doctors who include and inform the patients in the trials. They prescribe their treatment, are responsible for monitoring patients, in accordance with the protocol, and for the collection of data.
  • The research nurses and clinical study coordinators assist the researchers throughout the trial. Their role is to inform patients, manage appointment planning, administer the treatment (especially in Phase 1), gather information, manage communication between the different parties involved in the study and to implement the technical requirements of the protocol. They are the point of contact for the patient, researchers and those promoting the study.
  • The data managers are the encoders who assist the study coordinators and provide information relating to the clinical trials to the promoter of the study (a pharmaceutical firm or academic centre).
  • The administrative & start-up coordinator is an administrative assistant who assists the researcher in setting up all new research projects at the Institut Bordet.
  • The quality manager implements and manages standardised operating procedures to facilitate the execution of quality clinical trials, in accordance with the rules of good clinical practice. She designs and implements methods and tools available to the CTCU for the maintenance and development of quality.

CTCU Operations Manager
Michel Dubuisson

Quality Manager
Ana De Veciana

Administrative & start up coordinator
Sarah Peault

Data managers
Catherine Randour
Iraida Agaeva
Marie-Caroline Delhaye
Sylvestre Lare
Patricia Ndaya Bilolo
Aidi Amale

Administration
Bastienne Bouché

PSOM and Trial Submission CTCU
Marie-Aline Echterbille

Study (Nurse) Coordinators : 

  • For Medical Oncology and Radiotherapy
    Sylvie Bartholomeus
    Annakim Bergström
    Maureen Billiet
    Fanny Bustin
    Alfino Buttice
    Nathalie De Naeijer
    Berline Tako
    Metz Gaëlle
    Joana Neto
    Rana Ali Osman
    Michèle Schroeder
    Sophie Stylen  
     
  • For Anatomo-Pathology (management of biopsies)
    Alfonsa Laragione
     
  •  For Haematology
    Dominique De Poorter
    Sabrina Costantini
    Delphine Léva
    Lina Adu Poku  
     
  • For Radiotherapy
    Clémence Al Wardi
    Hélène Gilson  
     
  • For Thoracic Oncology, Oncological Emergencies and Intensive Care
    Nathalie Leclercq
     
  • For Infectology
    Vanessa Coubeaux
     
  • For Nuclear Medicine
    Wendy Delbart
    Loubna Taraji Schiltz
    Gabriella Critchi

 

12/04/2021

Publications

Le cancer du sein ne disparaîtra pas mais aider la recherche c'est aider à ce qu'il ne tue plus.

Cancer du sein : l'oncologue Martine Piccart à l'honneur

Des chercheurs belges préparent un traitement révolutionnaire contre le cancer

  • 11 Janvier 2017 – Dr Awada (RTL INFO)
  • http://www.rtl.be/info/magazine/sante/des-chercheurs-belges-preparent-un-traitement-revolutionnaire-contre-le-cancer-882053.aspx

Programme PRECISION, commentaires du Dr Philippe Aftimos

  • Belgian Oncology - 17/12/14
  • http://www.lejournaldumedecin.com/oncologie/actualite/programme-precision-commentaires-du-dr-philippe-aftimos/article-normal-20033.html 

 

Economie de la santé : 14% de chimiothérapies inutiles ?

Cancer : une thérapie ciblée sur le profil de la tumeur

  • Journal en ligne : L'ECHO - 8/5/2015
  • http://www.lecho.be/dossier/maladies_du_siecle/Cancer-une-therapie-ciblee-sur-le-profil-de-la-tumeur/9630983

Follow us!

Youtube

The New Jules Bordet Institute.

The New Jules Bordet Institute, located on the university campus of the ULB in Anderlecht, is ready and will soon welcome its first patients. A new state-of-the-art hospital entirely dedicated to the fight against cancer.